Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Institut für translationale Immunologie (TIM)

Vorklinik / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Matzner, Johannes; Pickert, Geethanjali; Fittler, Nicola J. et al.

STRUCTURALLY ENGINEERED FATTY ACID SEFA-1024 ALLEVIATES COLITIS IN MICE BY RESTORING INTESTINAL MUCOSAL BARRIER FUNCTION

GASTROENTEROLOGY. Bd. 160. H. 6. 2021 S. S617-S617


Ventura, Manuel A. Encalada; Hils, Martin; Tewes, Bernhard et al.

THE ORAL TISSUE TRANSGLUTAMINASE INHIBITOR ZED1227 PREVENTS GLUTEN-INDUCED ENTEROPATHY IN A TRANSGENIC MOUSE MODEL OF CELIAC DISEASE

GASTROENTEROLOGY. Bd. 160. H. 6. 2021 S. S53-S54


Cerf-Bensussan, Nadine; Schuppan, Detlef

The Promise of Novel Therapies to Abolish Gluten Immunogenicity in Celiac Disease

GASTROENTEROLOGY. Bd. 161. H. 1. 2021 S. 21-24




Matzner, Johannes; Pickert, Geethanjali; Thies, Dorothe et al.

A GUT-TARGETED EICOSAPENTAENOIC ACID DERIVATIVE, SEFA-1024, AMELIORATES DEXTRAN SODIUM SULFATE (DSS)-INDUCED INTESTINAL INFLAMMATION

GASTROENTEROLOGY. Bd. 158. H. 6. 2020 S. S505-S505


Schuppan, D

A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.

J Hepatol. Bd. 10.1016/j.jhep.2019.11.024. 2020 S. 19


Yurugi, Hajime; Zhuang, Yinyin; Siddiqui, Farid et al.

A subset of flavaglines inhibits KRAS nanoclustering and activation

JOURNAL OF CELL SCIENCE. Bd. 133. H. 12. 2020


Abe, Hiroyuki; Schuppan, Detlef

beta-arrestin: Dr Jekyll and Mr Hyde in NASH and fibrosis

JOURNAL OF HEPATOLOGY. Bd. 72. H. 5. 2020 S. 813-815